HLA Typing Market Size, Trends, Share, Growth | Report 2022-2030
The global HLA typing market was surpassed at USD 1.3 billion in 2021 and is expected to hit around USD 2.11 billion by 2030, growing at a CAGR of 5.53% from 2022 to 2030.
HLA also termed human leukocyte antigen typing is a type of genetic test that is also sometimes referred to as tissue typing. These are the proteins (markers) found in the cells of the body. HLA are the genes of MHS for protein-coding to distinguish between self and non-self. It helps to identify the bacteria and viruses that attack the body or other infections. The test is performed to evaluate whether a person is safe to donate bone marrow, organ, or cord blood for transplant or tissue transplant. For the test, the blood sample or the swab inside the cheeks is required of both the donor and recipient. There are three types of HLA namely HLA-A, HLA-B, HLA-DR.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 1.3 billion |
| Revenue Forecast by 2030 | USD 2.11 billion |
| Growth rate from 2022 to 2030 | CAGR of 5.53% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product, Technique, Application, End user, Region |
| Companies Covered |
Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Luminex Corporation, Qiagen N.V., Omixon Inc., Genome Diagnostics B.V., Illumina Inc., Immucor Inc., TBG Diagnostics Limited, Fujirebio Holdings Inc., Dickinson and Company, Beckton, Takara Bio Inc., F. HOFFMAN-LA ROCHE LIMITED, Pacific Biosciences, inno-Train Diagnostik GmbH among others |
Based on the health condition there are two types of transplants -
The prevalence of genetic disorders, autoimmune diseases, and chronic diseases has increased. The procedures of organ transplant and bone marrow donation have increased to cure these disorders. There is an increasing prevalence of diseases like sickle cell disease, and thalassemia which boosts the market. HLA typing has a wide range of applications in renal transplant, platelet transfusion, paternity testing, and diagnosis of ankylosing spondylitis. It can also be used to diagnose diseases like narcolepsy, rheumatoid arthritis, stem cell transplant, and Behcet’s disease which paves the way to accelerate the market for HLA typing. Recently in May 2022, a detection kit named DiscoverSeries HLAB*27 for in vitro diagnosis of Ankylosing spondylitis was launched by Mylab Discovery Solutions. The demand for molecular diagnostic tests has increased due to their promising results. So there is increasing consumer demand for HLA typing tests which drives the market. But the gene sequencing tests and molecular tests are costly which thwart the adoption and market growth to an extent.
The market is segmented based on the product, technique, application, end-user, and region. The product segment is divided into instruments, reagents and consumables, software and services. The technique segment is divided into molecular assay, sequenced based molecular assay, and non-molecular assay. The application segment is divided into diagnostic applications and research applications. The diagnostic application can be further sub-segmented into donor-recipient cross-matching, infectious disease testing, cancer diagnosis and prevention, transfusion therapy. The end-user segment is divided into hospital and transplant centers, research laboratories, and independent reference laboratories. The region segment is further segmented by North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
As per the regional analysis research, North America holds the market due to the rising genetic disorders. So there are advanced healthcare and research facilities available. Moreover, the government and companies are focused on the advancements in organ transplant which accelerates the HLA typing market. Asia-Pacific region also holds a significant market due to the improved infrastructure of the healthcare facilities, better healthcare reimbursement policies, and better economic growth which positively boosts the market. Along with this skilled professionals and availability of the transplant hospitals, and laboratories with advanced technologies will boost the market.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on HLA Typing Market
5.1. COVID-19 Landscape: HLA Typing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global HLA Typing Market, By Product
8.1. HLA Typing Market, by Product, 2022-2030
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Reagents and Consumables
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Software and Services
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global HLA Typing Market, By Technique
9.1. HLA Typing Market, by Technique, 2022-2030
9.1.1. Molecular Assay
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Sequenced-based Molecular Assay
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Non-Molecular Assay
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global HLA Typing Market, By Application
10.1. HLA Typing Market, by Application, 2022-2030
10.1.1. Diagnostic Application
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Research Application
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global HLA Typing Market, By End user
11.1. HLA Typing Market, by End user, 2022-2030
11.1.1. Hospitals and Transplant Centers
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Research Laboratories
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Independent Reference Laboratories
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global HLA Typing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Technique (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End user (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Technique (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End user (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Technique (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End user (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Technique (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Technique (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End user (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Technique (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End user (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Technique (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End user (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Technique (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End user (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Technique (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End user (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Technique (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End user (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Technique (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End user (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Technique (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End user (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Technique (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End user (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Technique (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End user (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Technique (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End user (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Technique (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End user (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Technique (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End user (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Technique (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End user (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Technique (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End user (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Technique (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End user (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Technique (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End user (2017-2030)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Laboratories Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Luminex Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Qiagen N.V.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Omixon Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Genome Diagnostics B.V.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Illumina Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Immucor Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. TBG Diagnostics Limited
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Fujirebio Holdings Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers